With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.52522-40-4,Tris(dibenzylideneacetone)dipalladium-chloroform,as a common compound, the synthetic route is as follows.
0.1127g (0.4871mmol) of Me-TtBQ, 0.1755g (1.218mmol) of dmfu and 0.2101g (0.2030mmol) of [Pd2(DBA)3¡¤CHCl3] were dissolved under inert atmosphere (Ar) in 30ml of anhydrous acetone. The mixture was stirred for 60min and eventually treated with active charcoal for 5/10min and filtered on Celite filter. The resulting yellow solution was dried under vacuum and the residual treated with diethyl ether, filtered off, washed with diethyl ether in excess and dried under vacuum. 0.1452g (yield 75percent) of the title compound was obtained as pale yellow microcrystals.
52522-40-4 Tris(dibenzylideneacetone)dipalladium-chloroform 11029508, acatalyst-palladium compound, is more and more widely used in various.
Reference£º
Article; Canovese, Luciano; Visentin, Fabiano; Biz, Chiara; Scattolin, Thomas; Santo, Claudio; Bertolasi, Valerio; Polyhedron; vol. 102; (2015); p. 94 – 102;,
Chapter 1 An introduction to palladium catalysis
Palladium/carbon catalyst regeneration and mechanical application method